despite the spike in covid cases around the country companies are looking to the other side of the pandemic as we make progress on a vaccine. pfizer out today with big news it applied for fda emergency use of its vaccine and corporate america sending signals of an all clear. nike, merck, kohl's and costco, more and more companies getting comfortable forecasting the future the number of big businesses issuing forward guidance up 30% from last quarter. corporate america is looking to the other side is it time for investors to do the same brian kelly, what do you say >> well, i think it is great, first of all, that corporate investors, corporations have a little bit more clarity, but that's what this whole reopening trade was about. from the bottoms, that was the whole thing, you are not going to have clarity, but when you do, boy, then it will be really good let's look at what we had this week we had good news on the vaccine. we had multiple companies up their dividend we also had multiple companies come out and feel much more comfortable with giving guidance however, the market was basically flat to down this week so to me this information is probably already priced in and, you know, if i'm a home gamer and saying is now the time to get in, it is probably not, at least not on this news now, we still have this tug-of-war is the vaccine going to be ready enough are we going to have another lockdown and we're going to have q1 gdp brink that's negative that's the tug-of-war going on in the market. in the news we got this week, it didn't resolve that unfortunately. >> that's exactly what jp morgan is forecasting, a contraction in q1 steve grasso, aren't we sort of throwing out next year in a way when it comes to multiples i mean in a way aren't investors looking through and just saying, you know what? it is a pass year almost >> i don't know if they're going to say it is a pass year i think the bar has gotten higher so i agree with the fact that companies now all of a sudden have a little bit of visibility because think back to march. there was nothing. we were flying blind we were flying blind on the show we were flying -- corporate america was flying blind everyone in the world was flying blind. now you have a flashlight. you don't have a spotlight, you have a flashlight. so i think people are starting to get more comfortable with the market, more comfortable with earnings let's remember, nike, this will make it the 19th consecutive year that they raised their dividend so i'm not sure if there's not a little bit of dressing up the window, if you will. i don't think that it is a contrived issue that they're doing, but just think about it i think bk makes a great point is this the top? is this a sell-the-news event? we've seen vaccine, a lot more beneficial news. we've gotten clarity on the election we've seen that balance of power with the republicans holding the senate we've gotten basically a goldilocks environment for what has been a terrible plague that hit this country and the world so if you are saying are we through it, i don't think we're through it but i think the market is pretty good at navigating and saying, hey, you know what? i think the worst is over. >> and we have asked that question, are these events the sell-the-news events, whether it be getting the vaccine news and having clarity as to when the first distribution could be made and getting through the bulk of the volatility of the election not to say there won't be still some volatility, but i think the biggest unknowns are now known at least in terms of having a winner bottom in would you agree it could be a sell-the-news? that would go starkly in the face of what has been a seasonal trade going to year-end which would be to go higher? >> i think given the fiscal stimulation, the support we've had, the news today notwithstanding, you do have and to use steve's term a goldilocks' situation where it is prime for risk assets in terms of looking to the other side, i mean i think, yes, that has been priced in there has been a look through to the other side, and that really explains the rotation out of some of the stay-at-home names, some of the technology names into some of the value plays what i'm looking at these dividend increases and tying all of that together, right, all of those companies with the exception of america are retail companies. we know that those companies have been able to be more efficient operating by slashing capacity, by slashing workforce and bringing that. so that's going to lead to inventory management we've already seen a rotation out of seasonal hiring yes, there will be more cash at hand, but what to me it is, that is a signal that we are seeing operational efficiencies leading to digitization of companies, that is here to say. i don't think that necessarily bodes well for employment. again, two-sided coin here. >> yeah. jeff, what is your take? >> you know, i think what we've been seeing has been going on for a little while now i know there's been a rotation going on and we've seen it cool off a little bit, but let's not forget, you know, you have value, industrials, materials, banks, wherever you want to go, they're up some 15%, 16%, 17% on the month. the fact they're cooling off a little bit isn't a huge shock to me the dividend story has been playing out for a little while now. it is the second straight month where we haven't seen any cuts or suspension, so i think it is a good thing companies now have $2 trillion of cash on their balance sheets, just as a perspective the previous peak was about $1.6 trillion i think it is interesting if you look at small caps, perhaps the most economically cyclical index you can find, and you have 70% of all earnings revisions actually being to the upside there. so that's the highest we've seen in 20 years. so i do think the market is doing a good job of looking to the other side of all of this. i think even if we see a slowdown in q4 or q1, which is probably likely, i think the market's perception of this slowdown versus what we saw, say, in february or march is going to be very, very different. i think that's what the market has been telling us for some time now as small has beaten large and value has beaten growth, interest rates have held in there but i do think stimulus has to be part of the equation here because this k-shaped recovery is very real 10 million people are still unemployed retail sales, for example, are slowing down as i said on the show last week i think the vaccine news makes stimulus in 2021 more likely because policymakers know they're building a bridge from today to a point in the future where activity can return to normal i think you take that in combination, i still want to play this rotation trade even if it ends up being choppy over the next couple of months. >> yeah, the general had mentioned small caps the russell is up 2.4% this week, brian kelly. where would you position yourself and do you think -- i think it is an interesting notion you know, jeff, when you first said that you thought that the vaccine news would make it more likely for stimulus i was like, i don't know it is growing on me. i like it better and better the more i hear it. >> i'll take it. >> brian kelly, what do you think of that? that at least if you know it is targeted, you know there's a finite amount of time, you know, you might be able to get some republican buy-in to let's spend this money on a package. >> yeah, i think that's right. if you think about, you know, why didn't we get any stimulus leading into the election, is that there really wasn't any political incentive to do that so now if you have a vaccine and you say, hey, listen, this is kind of a six-month problem in a sense, let's get through, let's build that bridge, i think you might be able to get a little bit more political buy-in. it is not likely to happen until we have the new administration, you know so i do think the market is correct in that sense, but, again, for me there's just so much uncertainty here in the u.s., i would rather look over to asia. i would rather look to japan i would rather look to china if i look at what is going on with nike to bring back to what we talked about at the top of the show, nike's growth is coming from asia if they are raising dividends and they feel comfortable, it is another leg to the kind of asia is going to take the growth baton from here. >> nike said back in september they expect the second half of the fiscal year to be up significantly when it comes to sales. would you agree? would you say u.s. may not be the best place to be right now >> i mean it is a global pandemic i mean, yes, i think emerging markets right now look attractive i wouldn't say in wrianywhere oe the u.s. europe still has challenges. buffet has allocated resources generally speaking i dolike e.m., i think it correlates well for some of the natural resource plays as we do look forward to getting back to a normal situation, an economic environment. >> grassley, you have been on the natural resource train, too. >> yes i mean if you look at the value, that fits all into the value play outperforming growth play i have been in the diversified chemical space like trinseio, it is leforred to europe i think you can see a lot of the names, olen, wrk, really outperform going forward i am still in the value bucket and i expect them to outperform grossly over the next six months. >> let's talk a little zoom talking the tape as the stay-at-home played out in a big way in today's session the stock could head higher as we gear up for a zoom thanksgiving that's right, families gathered around computers instead of dining room tables this year to keep socially distance the company is looking at a 40-minute time limit for free meetings on thanksgiving day are you feasting on this stay-at-home stock ahead of the holidays theoretically this could be the first time people start using zoom and they might think it is not so bad >> i think zoom is pretty well-known at this point i really don't think this singular event coming up in the holiday season is really going to be a revenue driver in the sense of looking at this being, you know, a long term or trending new actualization of revenue streams. so, no, i'm not buying in on the news you look forward to the -- i'm sorry. you look forward to the pe ratio out to 2021, up cloets tose to . it has just had one of those runs this is not a catalyst for investing. if you are not in it now, i don't think it is time to get involved. >> a lot of the stay-at-home trades got slaughtered on the vaccine news and zoom had one of the biggest weekly drops it had ever seen. jeff mills, what do you think of zoom here and some of the other -- i mean we are talking ea for instance, peloton, those are all up today. >> they are. but i'm with bonwyn on this one. usually when you see the stay-at-home names up on day you see growth on the day, you see tech do well it is kind of an overall virus stay-at-home trade you did not see it today value outperformed growth by 30 or 40 basis points, small outperformed large by around 75 basis points i thought it was notable in the sense that value cyclical trade, although down, outperformed even when the stay-at-home names were up i think you get to a point where the growth and user adroppings adroppings -- adoption or whatever you want to call it are not likely to materialize in the future that's where i think we are right now. it is not necessarily these stocks can't go up from here, i think they can but when you are thinking about relative outperformance and where you want to be, i want to be in small caps emerging from a 2 1/2 year bear market i want to be in japan breaking out after a 30-year bear market. these are areas i think can outperform over the next 12 months versus some of the other areas that i think have just done so well and the valuations are so extended you probably need totake a breath here. >> how about a name like peloton, brian kelly i'm asking you because you are a biker. so you have some experience with this area. >> yes. >> but it is also theoretically entering a seasonally strong period, i mean going into year-end, into january, people typically make all sorts of resolutions about getting in shape and losing weight. here we are, peloton >> right and peloton -- i mean peloton has been on an absolute tear i think it is kind of a permanent shift here because those are relatively expensive bikes. once you buy that, you are likely to kind of stick with that type of thing but this entire trade, this zoom trade ahead of thanksgiving reminds me of a simpson's episode. i am a huge fan of the simpsons. you may be too, melissa, i'm not sure but homer simpson makes a future in pumpkin futures, makes a fortune, but critically he f forgets to sell before halloween. that's the key you have to sell before halloween. you have to sell zoom before thanksgiving because the trade is over. >> i like how you connect it to popular culture. breaking news on the vaccine front. >> reporter: after the news that pfizer and biontech submitted their authorization to the fda, the fda now set the date for the outside meeting of their advisers to discuss the application. december 10th. now, that is along the lines of what we heard they asked the committee members to set aside, december 8th, 9th and 10th it is december 10th to discuss this request for emergency use authorization. that is a key step before the fda would potentially green light this vaccine for market. so we are looking at just a number of weeks before this could start to get distributed now a lot of people wonder why so long. well, we talked with the doctor from operation warp speed this morning who noted the fda, now that it has the application, needs to look through thousands of pages of data and graphs on everything from the efficacy to the safety to the manufacturing standards of this vaccine and analyze all of that and put it together for the committee members, then to look through and discuss. they will release all of that information in briefing documents two days ahead of the meeting on december 8th, well at least two days they may release it sooner than that now we have a timeline from the fda confirmed, december 10th for the outside meeting of advisers. after that they could green light it for market. >> definitely good news. meg, i'm curious if the fda has to digest all of those pages of data, could we see three weeks after december 10th for a moderna review if it takes that much time to get through all of that stuff >> reporter: that's a really good question. i mean do they have a second set of folks there to be able to look through moderna's application? because we are expecting moderna will file within a few weeks from monday when they had their data so, you know, within a couple of weeks. we were told end of november, early december he expected we could see a few days apart for the advisory committee meetings for pfizer and moderna and presumably a few days apart for the fda decision. you're right, the reviewers have a lot of work to do overcoming weeks. >> lots of overtime for them thank you, meg terrell steve grasso, your pick? >> i think you have to buy a bas basket of these and an index if you look at the vaccine plays, they topped out in july then we have this secondary headline phase going into the real vaccines. it looks like they topped out again. pfizer is well off its high from just a couple of days ago. when i say well off of it, it is 6% off in the same week so when you start to look at these names, melissa, you can't be buying these names -- if i asked you what pfizer was up year-to-date, people would get this wrong without looking it is only -- it is down 1% year-to-date now, moderna is up 400% because it has been on the scene a lot shorter time you can't buy the vaccine news more than one or two pops. i would say sell these names and buy the economy versus these names. >> we had an analyst who covers these names on yesterday who was saying he expects prices to come down dramatically from when the vaccine first hit the markets and he wouldn't want to be long these names as they enter the manufacturing phase which would prove difficult. where do you stand on these? >> he think he makes a good point. i said for a long time, listen, steve said it, i said it, guys have said it, trying to pick the winning horse out of this race is impossible. pfizer was up dramatically and traded off we've seen similar price action with moderna i think you do express this view in some of the these names you have to have legitimate company, of a supply of drugs, manufacturing efficacy and all of the above to still be in operations and do so at margins that will support the levels we are at right now so i'm fully in agreement with what he just said. coming up, tan on a tear that's right, the solar etf and rally mode this year should you buy or will you get burned first, bitcoin going bananas bk is here, straight ahead need better sleep? try nature's bounty sleep 3 a unique tri layer supplement, that calms you helps you fall a sleep faster and stay a sleep longer. great sleep comes naturally with sleep 3 only from nature's bounty anshaped by technologyr. grchand human ingenuity,s.y we can make it work for you and your business. ♪ i feel like we're forglet me check.ing. xfinity home gives you peace of mind from anywhere with professionally monitored home security built around you. no, i think we're good. good. so when you're away, you don't have to worry. the tent. we forgot... the tent. except about that. xfinity home. simple. easy. awesome. hey look, i found the tent! get xfinity home with no term contract required. click or call today. welcome back to "fast money. we have a bitcoin alert, the cryptocurrency up nearly 15% listen to what black rock chief investment officer rick reeter said about it earlier on cnbc. >> i think cryptocurrency is here to say and i think it is a durable. you have seen central banks that talked about digital currency. i think digital currency and particularly millennials re-september ift of technology and cryptocurrency is real digital payment systems is real. i think it is here to say. is it a durable mechanism that i think will take the place of gold to a large extent yeah, i do, because it is more functional than passing a bar of gold around. >> wow so black rock is saying bitcoin could replace gold one day b.k., i feel like rick rieder tuned in to "fast money" three years ago he would have heard the same argument from you. >> yes, he would have. it is nice to see somebody like rick able to say that because i'm sure he has done his research on this it really reflects the mindset, the change in mindset that institutional investors have had now versus three years ago so three years ago i talked to institutional slef investors and they say, hey, bk, i can't invest in this my risk management team won't let me touch it. now they are saying, wait, i got to buy this thing, i have to be in it. that's what we're seeing in the market and it is reflected in the price. what is kind of interesting, what we're seeing is there is in the relatively short term a bit of a coin shortage you are seeing institutions, high net worth slids buying coins, taking them off exchange, putting them in cold storage with a five or ten-year view on these. that creates a lack of supply. so that's what has been driving the price. the final thing i would just say though is that you have to have a long-term view on this we did a piece on this show back in 2016, bitcoin was at $899 and we asked the question, is it too late to buy bitcoin. of course, the answer now is no, it wasn't, right but, remember, bitcoin went from 1200 down to 700 before it came all the way back up here so the point is if you are going to buy bitcoin understand it is incredibly volatile and have a long-term view. >> 2016 bitcoin on this show amazing. coming up, solar stocks are on fire this year. wll the rally keep up weill debate that trade next hi, my name is sam davis and i'm going to tell you about exciting plans available to anyone with medicare. many plans provide broad coverage and still may save you money on monthly premiums and prescription drugs. with original medicare you're covered for hospital stays and doctor office visits, but you have to meet a deductible for each and then, you're still responsible for 20 percent of the cost. next, let's look at a medicare supplement plan. as you can see they cover the same things as original medicare, and they also cover your medicare deductibles and co-insurance, but they often have higher monthly premiums and no prescription drug coverage. now, let's take a look a humana's medicare advantage plans. with a humana medicare plan, hospital stays, doctor office visits, and medicare deductibles are covered. and, of course, most humana medicare advantage plans include prescription drug coverage. in fact, in 2019, humana medicare advantage prescription drug plan members saved and estimated 7,800 dollars on average on their prescription costs. most humana medicare advantage plans include a silver sneakers fitness program at no extra cost. dental and vision coverage is now included with most humana medicare advantage plans, and you get telehealth coverage with a zero dollar co-pay. you get all this for as low as a zero dollar monthly plan premium in many areas, and your doctor and hospital may already be a part of humana's large network. if you want the facts, call right now for the free decision guide from humana. there is no obligation, so call the number on your screen right now to see if your doctor is in our network, to find out if you can save on your prescriptions, and to get our free decision guide. humana - a more human way to healthcare. welcome back to "fast money. finally for the move of the day. invesco solar rising more than 2% to a record close the fund has been on a tear recently in hopes the biden administration will be more friendly to alternative energy bonawyn, you had a fast pitch on this that worked out well with first solar. where do you go from here? >> listen, i still think there's room to run here, all right. you talk about the biden administration, and we've had some developments in terms of tariffs. 1% is still the renewable energy consumption in the united states, so i still think there's upside i think it comes at the expense of traditional energy. first solar, run, tan, still think they all look good here. >> all right time for the trade around the horns steve grasso >> capri holdings. it basically doubled i think it will do it again. >> the general, jeff mills. >> small cap exposure but i want it via sly >> bonawyn >> fading the xle. >> bk? >> a way to play comermerce, pl >> that does it for us "move of the day" is sponsored by global x. when i was in high school, this was the theater i came to quite often. the support we've had over the last few months has been amazing. it's not just a work environment. everyone here is family. if you are ready to open your heart and your home, check us out. we thought for sure that we were done. and this town said: not today. ♪ ♪ ♪ dancing with myself ♪ ♪ ♪ ♪ "options action. strategies from the streets to happy friday "options action" fans we have another great show lined up for you coming up next friday is black friday. if you are not planning on shopping, you might not be alone. that's why you should be preparing options trades instead. carter worth will explain why. then -- tony zhang is going to make you sweat! then yell at you to work harder. then turn up the background music to deafening, all from the comfort of your living room.

Related Keywords

Japan , United States , America , Sam Davis , Tony Zhang , Brian Kelly , Melissa Lee ,